Sergey Avtushenko
Director/Board Member at PHARMSYNTHEZ
Profile
Sergey Sergeevich Avtushenko is currently the Director at Pharmsynthez PJSC and the Director at SynBio LLC.
Previously, he worked as the Executive Director at H & H LLC from 2003 to 2007 and as a Member-Management Board at Pharmavit Holding.
Mr. Avtushenko completed his undergraduate degree at Pavlov First Saint Petersburg State Medical University.
Sergey Avtushenko active positions
| Companies | Position | Start |
|---|---|---|
| PHARMSYNTHEZ | Director/Board Member | - |
SynBio LLC
 SynBio LLC Pharmaceuticals: MajorHealth Technology SynBio LLC engages in original research and introduction of conceptually new medicines. The firm’s medicines help treat diseases like liver disease, cardiovascular disease, acute leukemia, growth hormone deficiency and diabetes milletus. Its work is based on scientific developments and conducted in cutting edge laboratories. The company was founded in 2011 and is headquartered in Moscow, Russian Federation. | Director/Board Member | - |
Former positions of Sergey Avtushenko
| Companies | Position | End |
|---|---|---|
| H & H LLC | Director/Board Member | 2006-12-31 |
| Pharmavit Holding | Corporate Officer/Principal | - |
Training of Sergey Avtushenko
| Pavlov First Saint Petersburg State Medical University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PHARMSYNTHEZ | Health Technology |
| Private companies | 3 |
|---|---|
| H & H LLC | |
| Pharmavit Holding | |
SynBio LLC
SynBio LLC Pharmaceuticals: MajorHealth Technology SynBio LLC engages in original research and introduction of conceptually new medicines. The firm’s medicines help treat diseases like liver disease, cardiovascular disease, acute leukemia, growth hormone deficiency and diabetes milletus. Its work is based on scientific developments and conducted in cutting edge laboratories. The company was founded in 2011 and is headquartered in Moscow, Russian Federation. | Health Technology |
- Stock Market
- Insiders
- Sergey Avtushenko
